Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · IEX Real-Time Price · USD
3.370
-0.230 (-6.39%)
At close: Jul 2, 2024, 4:00 PM
3.460
+0.090 (2.67%)
After-hours: Jul 2, 2024, 7:45 PM EDT
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $496.63 million as of July 2, 2024. Its market cap has decreased by -50.41% in one year.
Market Cap
496.63M
Enterprise Value
412.83M
1-Year Change
-50.41%
Ranking
Category
Stock Price
$3.37
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.88B to $496.63M, a decrease of -89.81%. That is a compound annual growth rate of -36.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 530.50M | -25.22% |
| Dec 29, 2023 | 709.40M | -35.07% |
| Dec 30, 2022 | 1.09B | -72.41% |
| Dec 31, 2021 | 3.96B | -51.03% |
| Dec 31, 2020 | 8.09B | 117.39% |
| Dec 31, 2019 | 3.72B | -23.69% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 552.74M |
| National Research | 547.98M |
| SIGA Technologies | 539.82M |
| iTeos Therapeutics | 536.06M |
| Applied Therapeutics | 533.63M |
| SI-BONE | 532.78M |
| Third Harmonic Bio | 532.34M |
| Aveanna Healthcare Holdings | 530.97M |